PHARMA LITERATI

Date - 18th to 23rd Nov. 2019 Venue -  MET Institute of Pharmacy (Degree), Bhujbal Knowledge City, Bandra Reclamation (W), Mumbai 400050) Creativity and innovation in Teaching and Research is the basis of the knowledge sharing process between student and teacher but encapsulating it into your curriculum and subject poses a major challenge.The teachers will be enabled with recent advances in area like drug delivery systems, process validation, nanotechnology, applications of NMR, trouble shooting in chromatography, bioinformatics, and application of proteomics among others. These lectures will be supported by demonstrations and training in collaboration with National Facility of Biopharmaceutical (NFB) and Therapeutic Drug Monitoring Lab (TDM). Demonstration sessions include DNA finger printing, microscopy which is very useful in their routine teaching and research activities. We welcome the faculty members of all the disciplines from Pharmacy Institutes / Colleges to gain t

Source:  https://qcfi.in/

Source:  https://www.bioethicon.com/                

Source:  http://www.crsic.org/pdf/crs-brochure-for-national-event.pdf  

  Source: https://congress.sperpharma.org

The Indian healthcare sector is on a recovery path after two previous years of muted performance, marred by several regulatory measures, according to ICRA report. ICRA’s analysis of sample seven large companies reflects this robust performance trends in Q1 FY2020. Cumulatively the sample companies reported a healthy Y-o-Y ~14% increase in revenues and a 47% growth in EBITDA. This comes against the backdrop of a Y-o-Y 10% rise in revenues in FY 2019 as well as FY2018 and a muted 1% growth in EBITDA in FY2018 and an 8% increase in the same in FY 2019.  Further, the operating margin in Q1 FY 2020 stood at a healthy 13.6%, against an operating margin of 10.5% in the same quarter last year and full year operating margins of 12.4% in FY 2019. The sector’s performance had been adversely impacted in the past two years due to several regulatory measures, including the cap on prices of stents and knee implants by the National Pharmaceutical Pricing Authority (NPPA), adverse impact of t

Digital pharmacy startups are rapidly disrupting the pharmacy sector and continue to land significant venture capital funding deals. Pharmacy startup Capsule scored $200 million in a series C funding round led by venture capital firm TCV. Capsule’s existing investors Thrive Capital and Glade Brook Capital Partners also participated. The startup had previously raised $70 million and plans to expand outside of New York City to more large cities in the next 18 to 36 months, according to Bloomberg. India-based digital pharmacy startup Digi-Prex is leveraging the popularity of WhatsApp to provide consumers with prescriptions and to help manage chronic diseases. The company secured $5.5 million in its seed round of funding, led by Khosla Ventures. Vedanta Capital, Y Combinator, Quiet Capital and SV Angel also joined the round. Patients can share prescriptions online or via Whatsapp, pay a subscription fee on a monthly basis and get access to discounted medicines delivered to their

The biopharmaceutical industry has launched numerous initiatives on how to leverage artificial intelligence (AI) to advance drug development. For example, Pfizer expressed how AI can be used in drug discovery. Emerging biopharmaceutical companies (EBPs) are getting in on the AI action by leveraging AI to discover novel applications for shelved therapies that never made it to market. In this interview, Vimal Mehta, CEO, and Vince O’Neill, CMO, at BioXcel Therapeutics will discuss how they are actively using AI to discover advanced therapies in CNS and oncology. Moe Alsumidaie: Why is using AI and machine learning in drug development so unique, and how does it make an impact in the future of drug development? Vimal Mehta: I think information is growing at a much faster rate than in the past. And particularly in drug development, information flow is even more complex because it requires solid domain knowledge of science, the clinical side, the commercial side, the IP landscape and

Beyond epharmacy, 1mg has expanded into doctor consultations and diagnostic lab services As per DataLabs by Inc42 estimates, the total capital invested in epharma startups has been $361 Mn (2014-H1 2019) 1mg cofounder Gaurav Agarwal said the company has over 12 projects live that use proprietary AI and ML models      Online pharmacy startups such as 1mg, Pharmeasy, Netmeds and Medlife made medicines more easily available in a wider distribution area. On the other end, Practo, Lybrate, Portea, mfine, and DocsApp sprouted up in the telemedicine and diagnostics space to make access to doctors easier,and gradually, healthtech startups have changed the face of Indian healthcare over the past five years.      As per DataLabs by Inc42 estimates, the total capital invested in startups operating in the epharma space between 2015 to H1 2019 is $361 Mn. The total capital inflow in the online pharmacy startups combined makes up around 20% of the total capital invested in the healthtech